Human CD34+ Nucleofector Kit
| Cat. No. | VPA-1003 |
| Optimized Protocol | |
| Transfection Efficiency | After 20 hours: 71±11% |
| Cell Database |
In their role as hematopoietic progenitors CD34+ cells are of great interest to immunologists. Recently, they have also been shown to differentiate into other non-hematopoietic cells, such as endothelial precursors. So far, transfection of CD34+ progenitor cells has only been possible with viral methods or by electroporating stimulated cells. Using nucleofection, unstimulated CD34+ cells can now be transfected non-virally. For Nucleofection CD34+ cells can be derived from cord blood or leukapheresis material. Both fresh or cryopreserved material can be used.
- Up to 70% transfection efficiency
- Cited for DNA and siRNA transfection
- For unstimulated primary CD34+ cells
Example for nucleofection of CD34+ hematopoietic progenitor cells with H-2Kk cDNA.
Unstimulated peripheral blood mononuclear cells, partially enriched for CD34+ cells were transfected using the Human CD34 Cell Nucleofector Kit and a plasmid encoding the mouse MHC class I heavy chain molecule H-2Kk. 16 hours post nucleofection the cells were stained for CD34 and H-2Kk and analyzed by flow cytometry. Lymphocytes were gated according to forward/side scatter (A). Dead cells and CD34- cells were excluded by propidium iodide staining and gating (B and C). H-2Kk expression is shown after nucleofection without (D) and with plasmid DNA (E).
Components of Human CD34 Cell Nucleofector Kit
Cat. No. VPA-1003, 25 Reactions
| 25 | Plastic pipettes | |
| 25 | Certified cuvettes | |
| 10 | µg | pmaxGFP (for 5 reactions) |
| 0.5 | ml | Supplement |
| 2.25 | ml | Human CD34 Nucleofector Solution |




